1. A new life for rituximab?. Issue 3 (March 2016) Authors: Ghia, Paolo Journal: Lancet Issue: Volume 3:Issue 3(2016) Page Start: e103 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A single-tube multiplex method for monitoring mutations in cysteine 481 of Bruton Tyrosine Kinase (BTK) gene in chronic lymphocytic leukemia patients treated with ibrutinib. Issue 8 (3rd July 2021) Authors: Maffei, Rossana; Fiorcari, Stefania; Atene, Claudio Giacinto; Martinelli, Silvia; Scarfò, Lydia; Bonfiglio, Silvia; Maccaferri, Monica; Ljungström, Viktor; Zucchini, Patrizia; Forghieri, Fabio; Potenza, Leonardo; Ghia, Paolo; Marasca, Roberto; Trenti, Tommaso; Tagliafico, Enrico; Luppi, Mario Journal: Leukemia & lymphoma Issue: Volume 62:Issue 8(2021) Page Start: 2018 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Acalabrutinib monotherapy for treatment of chronic lymphocytic leukaemia (ACE-CL-001): analysis of the Richter transformation cohort of an open-label, single-arm, phase 1–2 study. Issue 12 (December 2021) Authors: Eyre, Toby A; Schuh, Anna; Wierda, William G; Brown, Jennifer R; Ghia, Paolo; Pagel, John M; Furman, Richard R; Cheung, Jean; Hamdy, Ahmed; Izumi, Raquel; Patel, Priti; Wang, Min Hui; Xu, Yan; Byrd, John C; Hillmen, Peter Journal: Lancet Issue: Volume 8:Issue 12(2021) Page Start: e912 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia: Results of the First Randomized Phase III Trial. Issue 31 (1st November 2021) Authors: Byrd, John C.; Hillmen, Peter; Ghia, Paolo; Kater, Arnon P.; Chanan-Khan, Asher; Furman, Richard R.; O'Brien, Susan; Yenerel, Mustafa Nuri; Illés, Arpad; Kay, Neil; Garcia-Marco, Jose A.; Mato, Anthony; Pinilla-Ibarz, Javier; Seymour, John F.; Lepretre, Stephane; Stilgenbauer, Stephan; Robak, Tad... Journal: Journal of clinical oncology Issue: Volume 39:Issue 31(2021) Page Start: 3441 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Acalabrutinib Versus Investigator's Choice in Relapsed/Refractory Chronic Lymphocytic Leukemia: Final ASCEND Trial Results. Issue 12 (14th December 2022) Authors: Ghia, Paolo; Pluta, Andrzej; Wach, Małgorzata; Lysak, Daniel; Šimkovič, Martin; Kriachok, Iryna; Illés, Árpád; de la Serna, Javier; Dolan, Sean; Campbell, Philip; Musuraca, Gerardo; Jacob, Abraham; Avery, Eric J.; Lee, Jae Hoon; Usenko, Ganna; Wang, Min Hui; Yu, Ting; Jurczak, Wojciech Journal: HemaSphere Issue: Volume 6:Issue 12(2022) Page Start: e801 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzumab for treatment-naive chronic lymphocytic leukaemia (ELEVATE-TN): a randomised, controlled, phase 3 trial. Issue 10232 (18th April 2020) Authors: Sharman, Jeff P; Egyed, Miklos; Jurczak, Wojciech; Skarbnik, Alan; Pagel, John M; Flinn, Ian W; Kamdar, Manali; Munir, Talha; Walewska, Renata; Corbett, Gillian; Fogliatto, Laura Maria; Herishanu, Yair; Banerji, Versha; Coutre, Steven; Follows, George; Walker, Patricia; Karlsson, Karin; Ghia, Pao... Journal: Lancet Issue: Volume 395:Issue 10232(2020) Page Start: 1278 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Acalabrutinib: a highly selective, potent Bruton tyrosine kinase inhibitor for the treatment of chronic lymphocytic leukemia. Issue 5 (16th April 2021) Authors: Ghia, Paolo; Dlugosz-Danecka, Monika; Scarfò, Lydia; Jurczak, Wojciech Journal: Leukemia & lymphoma Issue: Volume 62:Issue 5(2021) Page Start: 1066 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Are we finally getting personal? Moving towards a personalized approach in chronic lymphocytic leukemia. (September 2022) Authors: Albi, Elisa; Capasso, Antonella; Schiattone, Luana; Ghia, Paolo; Scarfò, Lydia Journal: Seminars in cancer biology Issue: Volume 84(2022) Page Start: 329 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Assessing Patients' Knowledge on Chronic Lymphocytic Leukemia: Validation of the ERIC CLL Knowledge Questionnaire in Greece. Issue 3 (23rd March 2021) Authors: Karamanidou, Christina; Xochelli, Aliki; Papaioannou, Maria; Moysiadis, Theodoros; Scarfo, Lydia; Mattsson, Mattias; Stavroyianni, Niki; Rosenquist, Richard; Ghia, Paolo; Stamatopoulos, Kostas Other Names: other. Journal: HemaSphere Issue: Volume 5:Issue 3(2021) Page Start: e546 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Challenges and Solutions for Collecting and Analyzing Real World Data: The Eric CLL Database as an Illustrative Example. Issue 5 (30th October 2020) Authors: Chatzidimitriou, Anastasia; Minga, Eva; Chatzikonstantinou, Thomas; Moreno, Carol; Stamatopoulos, Kostas; Ghia, Paolo Other Names: collaborator. Journal: HemaSphere Issue: Volume 4:Issue 5(2020) Page Start: e425 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗